# Efficacy and Safety of COVID-19 Convalescent Plasma

> **NCT04397523** · NA · COMPLETED · sponsor: **Institute for Transfusion Medicine of RNM** · enrollment: 200 (actual)

## Conditions studied

- Convalescent Plasma
- COVID-19
- SARS-CoV 2

## Interventions

- **BIOLOGICAL:** anti-SARS-CoV-2 convalescent plasma

## Key facts

- **NCT ID:** NCT04397523
- **Lead sponsor:** Institute for Transfusion Medicine of RNM
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-30
- **Primary completion:** 2021-05-10
- **Final completion:** 2021-05-10
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2024-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04397523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04397523, "Efficacy and Safety of COVID-19 Convalescent Plasma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04397523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*